Drugs & Side Effects |

Cancer Drugs News

FDA Gives Nexavar Fast Track Status for Liver Cancer

RSS News Feeds
Drugs & Pharmacuticals
Cancer Drugs
Fosamax
 All RSS Feeds

At a glance:

A drug that is currently in use for kidney cancer will received "fast track" review by the FDA for treating liver cancer patients. 
 
That means that Nexavar, made by Onyx Pharmaceuticals, may be available for this use sooner than would normally be the case. The FDA confers fast track status on drugs that are intended for life-threatening conditions where there is no approved satisfactory treatment.

Onyx drug gets 'fast track' status

Inside Bay Area - 6/14/2006 6:23 AM

Biopharmaceutical company Onyx Pharmaceuticals Inc. received news from U.S. regulators Tuesday that its drug Nexavar would receive an accelerated review for treatment of liver cancer.
 
On Tuesday, the U.S. Food and Drug Administration gave Emeryville-based Onyx and its partner on the drug, Bayer Pharmaceuticals Corp., "fast track" status, given to drugs that treat serious or life-threatening diseases where there is an unmet medical need. Liver cancer is the fifth most common cancer in the world, and is most prevalent in developing countries.
 
· Read The Full Cancer Drugs Article From Inside Bay Area -->

· Read All Cancer Drugs News Stories -->

Comments On Cancer Drugs News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: